Loading clinical trials...
Loading clinical trials...
A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY OF TANEZUMAB ON PERIPHERAL NERVE FUNCTION IN PATIENTS WITH OSTEOARTHRITIS.
Conditions
Interventions
tanezumab
tanezumab
+1 more
Locations
97
United States
NEA Baptist Clinic
Jonesboro, Arkansas, United States
JDP Medical Research, LLC
Aurora, Colorado, United States
Alpine Neurology
Centennial, Colorado, United States
Peak Anesthesia
Centennial, Colorado, United States
JEM Research, LLC
Atlantis, Florida, United States
Medical Specialists of the Palm Beaches
Atlantis, Florida, United States
Start Date
May 18, 2009
Primary Completion Date
November 16, 2010
Completion Date
November 16, 2010
Last Updated
February 4, 2021
NCT07153471
NCT07351968
NCT06381791
NCT06747494
NCT07327931
NCT06906939
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions